The Oncogene Metadherin Modulates the Apoptotic Pathway Based on the Tumor Necrosis Factor Superfamily Member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in Breast Cancer

Resistance to TRAIL and how to surmount it

(2012) Danijela Maksimovic-Ivanic et al.   IMMUNOLOGIC RESEARCH

Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition

(2011) Xiaoyan Li et al.   CANCER SCIENCE

Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin

(2011) Mi Jin Yoon et al.   CARCINOGENESIS

Metadherin as a link between metastasis and chemoresistance

(2011) Yong Wei et al.   CELL CYCLE

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

(2011) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer

(2011) Zhongmei Zhou et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of Novel Variants of Metadherin in Breast Cancer

(2011) Xianqiang Liu et al.   PLoS One

Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses

(2010) Claudia Bossen et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Significance of aeg-1 expression in correlation with vegf, microvessel density and clinicopathological characteristics in triple-negative breast cancer

(2010) Cong Li et al.   JOURNAL OF SURGICAL ONCOLOGY

Activation of the Akt Survival Pathway Contributes to TRAIL Resistance in Cancer Cells

(2010) Jing Xu et al.   PLoS One

Is TRAIL the holy grail of cancer therapy?

(2009) Thomas Newsom-Davis et al.   APOPTOSIS

MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer

(2009) Guohong Hu et al.   CANCER CELL

TRAIL as a target in anti-cancer therapy

(2009) Gen Sheng Wu   CANCER LETTERS

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

The Multifaceted Role of MTDH/AEG-1 in Cancer Progression

(2009) G. Hu et al.   CLINICAL CANCER RESEARCH

Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression

(2009) Byoung Kwon Yoo et al.   JOURNAL OF CLINICAL INVESTIGATION

Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice

(2009) S. Shankar et al.   MOLECULAR CANCER THERAPEUTICS

Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma

(2009) S -G Lee et al.   ONCOGENE

Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1

(2009) J Li et al.   ONCOGENE

Identification of genes conferring resistance to 5-fluorouracil

(2009) B. K. Yoo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CK2β Is Expressed in Endometrial Carcinoma and Has a Role in Apoptosis Resistance and Cell Proliferation

(2008) Judit Pallares et al.   AMERICAN JOURNAL OF PATHOLOGY

TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

(2008) Monzur Rahman et al.   BREAST CANCER RESEARCH AND TREATMENT

TRAIL receptor signalling and modulation: Are we on the right TRAIL?

(2008) Devalingam Mahalingam et al.   CANCER TREATMENT REVIEWS

Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival

(2008) J. Li et al.   CLINICAL CANCER RESEARCH

Aspirin Sensitizes Cancer Cells to TRAIL-Induced Apoptosis by Reducing Survivin Levels

(2008) M. Lu et al.   CLINICAL CANCER RESEARCH

The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11

(2008) C Chen et al.   ONCOGENE